Q2 2024
Released Aug 14, 2024, before the open
10-Q filed Aug 14, 2024, 45 days after period end · 0000868278-24-000010
Q2 2024 · 10-Q
Revenue$1.50M$1.50M −88.6% vs Q2 2023−36.2% vs Q1 2024
Net Income-$6.15M-$6.15M N/M vs Q2 2023N/M vs Q1 2024
EPS Diluted-$0.33-$0.33 N/M vs Q2 2023N/M vs Q1 2024
Gross Profit-$155,000N/M
Operating Income-$7,228,000N/M
Operating Cash Flowderived-$4,842,000N/M
Free Cash Flowderived-$4,842,000N/M
Margins · derived
Gross margin-10.3%−59.1 pt vs Q2 2023
Operating margin-480.6%−445.3 pt vs Q2 2023
Net margin-409.1%−383.1 pt vs Q2 2023
What the release said
The release
Same quarter
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $1.50M | $13.22M | $29.09M | $9.14M |
| Net Income | -$6.15M | -$3.44M | $7.45M | -$1.40M |
| EPS Diluted | -$0.33 | -$0.20 | $0.40 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR